Procter & Gamble Co.

Procter & Gamble Co.

PG

Get informed when a big investor buys or sells

+ Follow
Market Cap$374B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Procter & Gamble Co.Procter & Gamble Co.23.92.7%22%4.50.7

Earnings Call Q1 2027

October 22, 2026 - AI Summary

Strong start to FY27 with acceleration in organic sales (demand + share momentum) - Organic sales +4.0% YoY, supported by volume +2.4 points, pricing +0.4, mix +1.0+ (majority of growth driven by volume). - All 10 categories grew organically; Fabric Care, Home Care, Baby Care, Hair Care, Skin & Personal Care, Grooming grew mid-single digits; others low-single digits. - All 6 regions grew organically: North America +3%, Europe +4%, Greater China +8%, and Focus markets +4%. - Share improvement: Global aggregate market share flat, but U.S. top customer base improved sharply—70% of top U.S. customers holding or growing share, up from <10% in 1H FY26 and up from 50% in 2H FY26. Also 29 of 50 top category-country combinations are holding or growing share YTD (up from 25 in 2H FY26).
Bottom line supported by productivity leverage, but margins pressured by commodity/freight + investments - Core EPS $2.00 (described as +1 point vs prior year on a currency-neutral basis), while core gross margin -150 bps and core operating margin -80 bps YoY. - Productivity +250 bps offset higher costs from raw materials, energy, and freight (primarily North America) plus demand creation investments. - Free cash flow productivity: 93% (strong for the quarter).
Key near-term forecast: maintained full-year guidance, with H1 framed as ~3% organic growth - Company is maintaining fiscal 27 guidance ranges (organic sales, core EPS, and FCF productivity). - They expect H1 organic sales growth ~3%, targeting semester-by-semester acceleration into the back half (they compared to last year’s H1 cadence and emphasized quarter-to-quarter “wobble” from base/inventory/timing). - Full-year guidance (all-in GAAP includes Thorn acquisition): - Sales growth 1%–3% (organic growth expected volatile quarter-to-quarter). - Core EPS growth 0%–3% → $6.89 to $7.11. - FCF productivity 85%–90%. - Capital spending 4.5%–5.5% of sales.

Exclusive for Stockcircle Pro members

Sign upSign Up
$163.18

Target Price by Analysts

1.3% upsideProcter & Gamble Target Price DetailsTarget Price
$203.21

Current Fair Value

26.2% upside

Undervalued by 26.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$374.00 Billion
Enterprise Value$397.56 Billion
Dividend Yield$4.35 (2.70%)
Earnings per Share$6.75
Beta0.38
Outstanding Shares2,407,200,000

Return

Return on Equity21.92%ROE
Return on Assets9.07%
Return on Invested Capital23.37%

Valuation & Multiples

P/E Ratio23.85P/E Ratio
PEG-5963.7PEG
Price to Sales4.47Price to Sales
Price to Book Ratio7.32Price to Book Ratio
Enterprise Value to Revenue4.52
Enterprise Value to EBIT19.31
Enterprise Value to Net Income32
Total Debt to Enterprise0.1
Debt to Equity0.71Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
October 23, 2026
EPS Estimate
$1.89
Average shareholder expectation
Revenue Estimate
$22.72 B
Average shareholder expectation

Next Earnings Call

Expected Date
January 21, 2027
EPS Estimate
$1.85
Average shareholder expectation
Revenue Estimate
$22.82 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.3016▼ 53.02%
Total Calls18,900▼ 99.89%
Total Puts5,700▼ 99.96%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.24%▼ 67.00%
Total Invested$7.87B▼ 96.80%
Investors Holding1,327▼ 2827.00%

ESG Score

No data

About Procter & Gamble Co.

104,000 employees
CEO: David Taylor

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment off...